Back

Integrating Infection Burden and Multimodal Biomarkers for Early Detection of Alzheimers Disease: A Sheaf-ML Framework.

Thakur, L. S.; Bharj, G.; Nguyen, D.-T.; Saroya, M.; Malik, B.

2025-11-13 neurology
10.1101/2025.11.10.25339915 medRxiv
Show abstract

Alzheimers disease (AD) remains a major global health challenge, with growing evidence linking chronic infections, immune aging, and neurodegeneration. Grounded in the Antimicrobial Protection Hypothesis, this study introduces a sheaf-theoretic machine learning framework, Sheaf-ML, for integrating multimodal health data and assessing infection-related cognitive risk. Sheaf-ML constructs a unified patient-level representation that coherently combines diverse data streamsincluding serological infection markers, cognitive assessments, cardiovascular and metabolic measures, nutritional and behavioral evaluationswhile preserving the intrinsic structure and relationships of each modality. Applying this framework to the Harmonized LASI-DAD dataset (N = 6168), we modeled six clinically motivated domains (Infection, Cognition, Mental Health, Cardiovascular, Nutrition, and Demographics) and integrated them into a topologically consistent representation using learnable cross-domain mappings and consistency constraints. The sheaf-integrated embeddings revealed clinically meaningful interactions: infection burden was linked with cardio-vascular, nutritional, and cognitive outcomes, highlighting system-level coordination across modalities. Using these embeddings, Sheaf-ML produced interpretable patient-level predictions and identified the most influential features both globally and individually. We further derived an Infection Burden Index (IBI), which quantified patient-level infection-related risk. Patients exceeding the 80th percentile were flagged as early-warning cases, corresponding to approximately 20% of the cohort, demonstrating actionable stratification for clinical monitoring. This study provides the first empirical evidence that sheaf-based architectures can integrate multimodal health data in a clinically interpretable manner, uncover biologically meaningful interactions, and support patient-specific risk prediction. By linking population-level patterns with individualized insights, Sheaf-ML establishes a foundation for scalable, interpretable, and equitable precision models of infection-related cognitive decline in Alzheimers disease.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Nature Medicine
117 papers in training set
Top 0.1%
28.7%
2
Advanced Science
249 papers in training set
Top 0.5%
14.9%
3
Nature Communications
4913 papers in training set
Top 24%
7.4%
50% of probability mass above
4
Nature Biomedical Engineering
42 papers in training set
Top 0.1%
7.1%
5
Nature Aging
51 papers in training set
Top 0.4%
4.3%
6
Nature Computational Science
50 papers in training set
Top 0.1%
3.7%
7
npj Digital Medicine
97 papers in training set
Top 1%
3.0%
8
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 27%
2.2%
9
Nature Machine Intelligence
61 papers in training set
Top 1%
2.2%
10
Briefings in Bioinformatics
326 papers in training set
Top 3%
1.8%
11
eBioMedicine
130 papers in training set
Top 1.0%
1.8%
12
Nature
575 papers in training set
Top 13%
1.3%
13
Nature Cancer
35 papers in training set
Top 1.0%
1.3%
14
Scientific Reports
3102 papers in training set
Top 65%
1.3%
15
Med
38 papers in training set
Top 0.5%
1.0%
16
Communications Medicine
85 papers in training set
Top 0.6%
1.0%
17
Neuron
282 papers in training set
Top 8%
0.8%
18
Medical Image Analysis
33 papers in training set
Top 0.9%
0.8%
19
eLife
5422 papers in training set
Top 56%
0.8%
20
Cell Metabolism
49 papers in training set
Top 2%
0.8%
21
Computational and Structural Biotechnology Journal
216 papers in training set
Top 9%
0.8%
22
Science Advances
1098 papers in training set
Top 30%
0.7%
23
Frontiers in Aging Neuroscience
67 papers in training set
Top 4%
0.7%
24
Alzheimer's & Dementia
143 papers in training set
Top 3%
0.7%
25
Cell Stem Cell
57 papers in training set
Top 3%
0.5%
26
Cancer Cell
38 papers in training set
Top 2%
0.5%
27
The Innovation
12 papers in training set
Top 1%
0.5%
28
Nature Methods
336 papers in training set
Top 7%
0.5%
29
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.5%